Developing a Med Device Traceability Matrix

by | Apr 30, 2021 | FDA, ISO, Medical Devices, Testing

If you have developed a medical device, you know how important the concept of traceability is. Every facet of the medical device lifecycle requires traceability, from concept development, to manufacturing, to post-market. There are so many regulatory processes in place to ensure traceability by design that sometimes the simple methods can be overlooked. Every medical device that I have helped develop has utilized a robust traceability matrix. A traceability matrix is a simple visualization of the linkages between the key areas of design controls, such as design inputs, design outputs, and V&V activities.

Although not specifically required by any regulatory requirement or international standard, developing a traceability matrix is industry best practice and heavily recommended by both the FDA and ISO 13485:2016. In fact, both the “Planning of Product Realization” and “Design and Development Planning” clauses of ISO 13485:2016 talk about traceability activities and methods to ensure traceability.1

So, where to begin? The obvious starting point is defining User Needs. Next, you should translate your user needs into design inputs, then define design outputs, and finally trace to your verification and validation activities. This flow can be achieved in any number of ways, like using Excel or any other spreadsheet software. Visualizing the design and development process by showing the translation between columns can be an easy way to demonstrate traceability. This also creates one key location for all your pertinent design & development information.

Creating a traceability matrix for your medical device also ensures sustainability in your design controls process. By creating one simple visualization of how your product was developed, you create a “roadmap” for any team members that will come after you. This roadmap is what any regulatory inspector will want to see, so creating a robust traceability matrix can hold many purposes.

EMMA International has helped develop traceability matrices for several medical devices, whether it was creating one as part of a new product realization, or reverse-engineering one through a remediation effort. If you’re unsure where to start, or need help developing a robust trace matrix, our technical team is here to help! Give us a call at 248-987-4497 or email info@emmainternational.com to find out more.


1International Organization for Standardization (Feb 2016) ISO 13485:2016 Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes retrieved on 04/24/2021 from: https://www.iso.org/standard/59752.html

Madison Wheeler

Madison Wheeler

Director of Technical Operations - Ms. Wheeler serves as EMMA International’s Director of Technical Operations. She has experience in technical writing, nonconforming product management, issue evaluations, and implementing corrective and preventative actions in the pharmaceuticals and medical device industries. She has experience cross-functionally between R&D, lean manufacturing operations, and RA compliance. Ms. Wheeler also has academic and work experience with human health-risk engineering controls, physiological biophysics, and clinical research. Ms. Wheeler holds a Bachelor of Science in Biosystems Engineering with a concentration in Biomedical Engineering from Michigan State University. She is also a Certified Quality Auditor (CQA), and is currently pursuing her M.S. in Quality Management.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This